MIR3180-4: A Potential Drug Target and Biomarker (G100500852)

MIR3180-4: A Potential Drug Target and Biomarker

MIR3180-4, a nuclear transmembrane protein located in the endoplasmic reticulum, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure, localization, and function make it an intriguing candidate for further research and development as a therapeutic agent.

Structure and Localization

MIR3180-4 is a 21-kDa protein that consists of an N-terminal cytoplasmic domain, a transmembrane region, and an C-terminal cytoplasmic domain. It has a unique feature, known as a perforin domain, which is a type of ion-channel domain that is involved in the regulation of intracellular signaling pathways. The perforin domain is responsible for the protein's ability to interact with various signaling molecules, including phosphatidylserine (PS), a well-known protein that is involved in cell signaling and membrane structure.

MIR3180-4 is primarily localized to the endoplasmic reticulum, which is a protein synthesis and quality control system that plays a crucial role in the regulation of gene expression and protein synthesis. The endoplasmic reticulum is known for its robust quality control mechanisms, including the chaperone system, which helps to ensure the proper folding and localization of newly synthesized proteins. MIR3180-4's unique perforin domain allows it to interact with PS, which is also known to localize to the endoplasmic reticulum. This interaction between MIR3180-4 and PS may have implications for the regulation of intracellular signaling pathways and the function of endoplasmic reticulum-associated proteins.

Function

MIR3180-4 is involved in various cellular processes that are critical for normal cellular function and growth, including cell signaling, DNA replication, and protein synthesis. Its involvement in these processes makes it an attractive target for drug development due to its potential to modulate cellular behavior and promote therapeutic outcomes.

MIR3180-4 has been shown to play a role in the regulation of cell signaling pathways, including the insulin/IGF-1 signaling pathway. This pathway is involved in the regulation of glucose metabolism and has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR3180-4 has been shown to interact with the protein FKBP1, which is a component of the insulin/IGF-1 signaling pathway. This interaction may contribute to the regulation of insulin/IGF-1 signaling and the development of insulin-resistant states.

MIR3180-4 has also been shown to be involved in the regulation of DNA replication, a critical process for the maintenance of genetic diversity and the development of new organisms. Its involvement in this process may contribute to the regulation of genome stability and the risk of cancer.

MIR3180-4 has also been shown to play a role in the regulation of protein synthesis, which is critical for the development and maintenance of cellular structures and functions. Its involvement in this process may contribute to the regulation of cellular processes that are essential for normal cellular growth and development, including the development and maintenance of neuronal connections in the brain.

MIR3180-4 as a Biomarker

MIR3180-4 has also been shown to serve as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and localization make it an attractive candidate for diagnostic applications, including the detection and monitoring of cancer.

MIR3180-4 has been shown to be expressed in various tissues and cells, including cancer cells, neurodegenerative disease cells, and immune cells. Its expression may be used as a biomarker for the diagnosis and monitoring of these diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

MIR3180-4 has also been shown to have potential clinical applications in the treatment of various diseases, including cancer. Its unique structure and localization make it an attractive candidate for the development of new therapeutic agents that can target this protein and modulate its behavior.

Conclusion

MIR3180-4 is a unique and promising protein that has the potential to serve as a drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and localization, as well as its involvement in various cellular processes, make it an attractive candidate for further research and development as a therapeutic agent. Further studies are needed to fully understand the function and potential of MIR3180-4 and its implications for the development of new therapeutic approaches for various diseases.

Protein Name: MicroRNA 3180-4

The "MIR3180-4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3180-4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1 | MIR329-2 | MIR330 | MIR331 | MIR335 | MIR337 | MIR338 | MIR339 | MIR33A | MIR33B | MIR340 | MIR342 | MIR345 | MIR346 | MIR34A | MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667